The results were ranked based on the DC value to highlight IL1B, IL6, TNF, AKT1, CASP3, MAPK3, BCL2, TGFB1, MMP9, and PPARG, which were hypothesized to be key targets of LC treatment for myocarditis (Table 2). This evidence concerns the gene IL1B and myocarditis.